Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Bio-Protocol|November 11, 2024
Accurate Measurement of Cell Number-Normalized Differential Gene Expression in Cells Treated With Retinoic AcidNina Weichert-Leahey, Mark W Zimmerman, Alla Berezovskaya, et al.
The Journal of Clinical Investigation|May 15, 2023
Genetic predisposition to neuroblastoma results from a regulatory polymorphism that promotes the adrenergic cell stateNina Weichert-Leahey, Hui Shi, Ting Tao, et al.
Biorxiv : the Preprint Server for Biology|March 13, 2023
Genetic Predisposition to Neuroblastoma Results from a Regulatory Polymorphism that Promotes the Adrenergic Cell StateNina Weichert-Leahey, Hui Shi, Ting Tao, et al.
Nature Communications|December 11, 2019
ASCL1 is a MYCN- and LMO1-dependent member of the adrenergic neuroblastoma core regulatory circuitryLu Wang, Tze King Tan, Adam D Durbin, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2025
KAT6A/B inhibition synergizes with retinoic acid and enhances the efficacy of GD2-targeted immunotherapy in neuroblastomaNina Weichert-Leahey, Alla Berezovskaya, Mark W Zimmerman, et al.
Nature Communications|June 2, 2017
Corrigendum: Small genomic insertions form enhancers that misregulate oncogenesBrian J Abraham, Denes Hnisz, Abraham S Weintraub, et al.
Nature Communications|February 10, 2017
Small genomic insertions form enhancers that misregulate oncogenesBrian J Abraham, Denes Hnisz, Abraham S Weintraub, et al.
Nature Genetics|August 22, 2018
Selective gene dependencies in MYCN-amplified neuroblastoma include the core transcriptional regulatory circuitryAdam D Durbin, Mark W Zimmerman, Neekesh V Dharia, et al.
Pageof 2